Cite
HARVARD Citation
Meng, X. et al. (2021). Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial. Stroke and vascular neurology. 6 (2), pp. 274-279. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Meng, X. et al. (2021). Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial. Stroke and vascular neurology. 6 (2), pp. 274-279. [Online].